Key Responsibilities: Proactively identify and evaluate external opportunities across oncology, and autoimmune indications, including platform technologies, early-stage assets, and late-stage/commercial products; Translate corporate strategy into actionable search criteria; assessing how opportunities enhance Immunocore's pipeline, platform capabilities, or commercial footprint; Lead transactions end-to-end, including initial outreach, term sheet development, negotiation, and contract execution for licensing, collaborations, and acquisitions; Coordinate diligence efforts across R&D, clinical, regulatory, manufacturing, commercial, legal, and finance teams; Prepare and present investment cases to senior leadership and executive committees; support Board-level materials as needed; Develop and maintain strong relationships with biotech companies, academic institutions, venture investors, and advisors to position Immunocore as a partner of choice. Education, Experience and Knowledge: Essential Qualifications: Ideal candidate must have strong scientific background paired with business acumen; Bachelors degree in science, finance, business administration, or related field; Keen understanding of biological therapeutics, including evaluation of both pre-clinical and clinical stage opportunities in oncology and/or immunology; Experience scouting for innovative drug development partnerships including both academic and commercial partners; A deal sheet demonstrating execution of deals across a diverse range of deal types and structures (e.g.